Literature DB >> 16686771

Measles-associated encephalopathy in children with renal transplants.

A Turner1, D Jeyaratnam, F Haworth, M D Sinha, E Hughes, B Cohen, L Jin, I M Kidd, S P A Rigden, E MacMahon.   

Abstract

Two children, boys of 8 and 13 years, presented with measles-associated encephalopathy several years after kidney transplantation for congenital nephrotic syndrome. In the absence of prior clinical measles, the neurological symptoms initially eluded diagnosis, but retrospective analysis of stored samples facilitated the diagnosis of measles-associated encephalopathy without recourse to biopsy of deep cerebral lesions. Each had received a single dose of measles mumps and rubella vaccine before 12 months of age. Prior vaccination, reduction of immunosuppression and treatment with intravenous immunoglobulin and ribavirin may have contributed to their survival. Persistent measles virus RNA shedding, present in one child, was not controlled by treatment with i.v. ribavirin. Two years later, both patients continue to have functioning allografts with only minimal immunosuppression. These cases illustrate the difficulty in diagnosing measles-associated encephalopathy in the immunocompromised host, even in the era of molecular diagnostics, and highlight the renewed threat of neurological disease in communities with incomplete herd immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686771     DOI: 10.1111/j.1600-6143.2006.01330.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  The Reemergence of Measles.

Authors:  C L Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

Review 2.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

Review 3.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

Review 4.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

5.  Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation.

Authors:  Ulf Schönermarck; Teresa Kauke; Gundula Jäger; Antje Habicht; Thorsten Wendler; Joachim Andrassy; Markus Guba; Manfred Stangl; Michael Fischereder
Journal:  J Transplant       Date:  2011-12-08

6.  Waning of vaccine-induced immunity to measles in kidney transplanted children.

Authors:  Salvatore Rocca; Veronica Santilli; Nicola Cotugno; Carlo Concato; Emma Concetta Manno; Giulia Nocentini; Giulia Macchiarulo; Caterina Cancrini; Andrea Finocchi; Isabella Guzzo; Luca Dello Strologo; Paolo Palma
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 7.  Rare and emerging viral infections in transplant recipients.

Authors:  Jesse J Waggoner; Elizabeth A Soda; Stan Deresinski
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

8.  Local public health response to vaccine-associated measles: case report.

Authors:  Monica Hau; Kevin L Schwartz; Crystal Frenette; Isabelle Mogck; Jonathan B Gubbay; Alberto Severini; Joanne Hiebert; Shelley L Deeks; Shaun K Morris
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

9.  Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult Patients.

Authors:  Cédric Rafat; Kada Klouche; Jean-Damien Ricard; Jonathan Messika; Antoine Roch; Sonia Machado; Romain Sonneville; Olivier Guisset; Wilfried Pujol; Claude Guérin; Jean-Louis Teboul; Natacha Mrozek; Michaël Darmon; Frank Chemouni; Matthieu Schmidt; Emmanuelle Mercier; Didier Dreyfuss; Stéphane Gaudry
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.